Eisai expects Alzheimer's drug to rake in revenue of $66.5 million by March
Japanese drugmaker Eisai said on Tuesday it was targeting revenue of 10 billion yen ($66.5 million) from its
2023-11-07 22:25
Factbox-Companies in Alzheimer's race after US nod for Eisai/Biogen drug
Eisai Co Ltd and Biogen Inc's Leqembi emerged as the first Alzheimer's treatment to win the U.S. Food
2023-07-08 02:22
Explainer-Who is eligible for the new FDA-approved Alzheimer's drug?
By Deena Beasley The U.S. Food and Drug Administration on Thursday granted standard approval to Eisai and Biogen's Leqembi for
2023-07-07 05:58
US FDA grants standard approval of Eisai/Biogen Alzheimer's drug
By Deena Beasley and Julie Steenhuysen LOS ANGELES (Reuters) -The U.S. Food and Drug Administration on Thursday granted standard approval
2023-07-07 05:23